DEINOVE benefits from an experienced management team in research, development, finance and business development, a panel of high-level scientific experts and a Board of Directors highly qualified in the development of drugs and specialty compounds. This organization enables DEINOVE to develop an effective strategy that is relevant to the environment in which it operates.
MD, PhD in clinical pharmacology, MBA
PhD in Molecular and Cellular Biology, European Magister in Genetics, MBA
Master in Management Sciences and Management Control, Diploma in Accounting & Management, MBA
PhD in molecular pharmacology
MD, MSc, FFPM, Harvard Business School, HEC
University of Lyon 2, University of Bordeaux 3